|
All Business Categories
|
AVANIR Pharmaceuticals
California, USA Avanir Pharmaceuticals (Nasdaq: AVNR) is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Avanir's products an... XOMA Ltd. California, USA XOMA develops and manufactures antibody and other protein-based biopharmaceuticals for disease targets that include immunological and inflammatory disorders, cancer and infectious ... Myriad Genetics , Inc. Utah, USA Myriad Genetics, Inc. is a biopharmaceutical company focused on the development of novel healthcare products. The Company develops and markets molecular diagnostic products, and it... VIVUS , Inc. California, USA VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. VIVUS has t... Metabasis Therapeutics , Inc. California, USA Metabasis Therapeutics, Inc. (www.mbasis.com) is a privately held, biopharmaceutical company that develops proprietary products for the treatment of human disease with a current fo... Washington, USA This site is dedicated to providing informative information on the latest research on prostate cancer Albany Molecular Research , Inc. New York, USA Albany Molecular Research, Inc. is a global drug discovery company that provides chemistry services to pharmaceutical and biotechnology companies and conducts its own proprietary R... EntreMed , Inc. Maryland, USA Rockville, MD-based EntreMed, Inc., The Angiogenesis CompanyÔ, is a leader in the field of antiangiogenesis research, which involves the inhibition of abnormal blood vessel growth ... Cubist Pharmaceuticals , Inc. Massachusetts, USA CUBICIN (daptomycin for injection) is an antibiotic indicated for the treatment of complicated skin and skin structure infections (cSSSI), sometimes called surgical site infections... Pro-Pharmaceuticals , Inc. Massachusetts, USA Pro-Pharmaceuticals Inc. is a research leader in developing a new generation of Glyco-upgradeÔ oncologic drugs. We target sugar-specific binding sites found on cancer cells using c...
First
Prev
[1]
[2]
[3]
[4]
[5]
6
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[736]
[1453]
[2170]
Next
Last
|
